Invention Grant
US07902186B2 Substituted 5-phenyl-3,6-dihydro-2-oxo-6H-1,3,4-thiadiazines
有权
取代的5-苯基-3,6-二氢-2-氧代-6H-1,3,4-噻二嗪
- Patent Title: Substituted 5-phenyl-3,6-dihydro-2-oxo-6H-1,3,4-thiadiazines
- Patent Title (中): 取代的5-苯基-3,6-二氢-2-氧代-6H-1,3,4-噻二嗪
-
Application No.: US12094542Application Date: 2006-10-25
-
Publication No.: US07902186B2Publication Date: 2011-03-08
- Inventor: Oliver Schadt , Dieter Dorsch , Melanie Schultz , Andree Blaukat
- Applicant: Oliver Schadt , Dieter Dorsch , Melanie Schultz , Andree Blaukat
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: DE102005055354 20051121
- International Application: PCT/EP2006/010285 WO 20061025
- International Announcement: WO2007/057092 WO 20070524
- Main IPC: C07D285/18
- IPC: C07D285/18 ; A61K31/54 ; A61P35/00
Abstract:
Compounds of the formula (I), in which R1, R2, m, Q and B have the meanings indicated in Claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumours.
Public/Granted literature
- US20080318936A1 Substituted 5-Phenyl-3,6-Dihydro-2-Oxo-6H-1,3,4-Thiadiazines Public/Granted day:2008-12-25
Information query
